pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-122 |
Genomic Coordinates | chr18: 65248861 - 65248926 |
Synonyms | Mirn122a, mmu-mir-122, Mir122a |
Description | Mus musculus miR-122 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | ![]() |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-122-5p |
Sequence | 6| UGGAGUGUGACAAUGGUGUUUG |27 |
Evidence | Experimental |
Experiments | Cloned |
Putative Targets |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | P4ha1 | ||||||||||||||||||||
Synonyms | AL022634, P4ha | ||||||||||||||||||||
Description | procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide | ||||||||||||||||||||
Transcript | NM_011030 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on P4ha1 | |||||||||||||||||||||
3'UTR of P4ha1 (miRNA target sites are highlighted) |
>P4ha1|NM_011030|3'UTR 1 CAACCAGGCTTCCCTTGGCTCCTGTTGTCCTCTAACGCACCAGGCACGATGGCTGATTATAACTCCGACGTTTACAGCTG 81 ACTAACACTCCATGATTAATTGGGCCATGAGCCTCAGCCCCATGTCTCACCTGTGGACAATCACTTATTTTGTGGATTTC 161 TTTAATTAATACTCAATCACCACATGATGTAAAACTTATGGTTCAGTTTTCACAGGATACAAGGCATTGAAAATGAGGAA 241 CCTAATTTTGTTGTTTAAAAGAGCTTTTTGGTTAATTTTTTTAAAAAAAGCATCCAGAAGTAGATTTCACCACAAGTCAG 321 GAGCTGGTGGAGCAGGCGAGGCTGTGTGGCAGGCGTGCAGGTGGCAGGCGAGCAGAGCCTGTGGGCTTACAGACGGCAGG 401 CATGCAGACGCCAGTGTGCTGCTCTTCCGATGTGTGGACTGCTGAGCACTGGTAACTAACTAGGGCCCAGTCAGGTCTGC 481 TATTCCACGTGCAGAGTTCCTATTATTTAAAGAAACTCTTTTTATCAAATCCCCCTCCTCACCACGGGTGAATTCAGCCA 561 GTTTGAGAAAATTACTTTGTTCAAAAAGTCCTGCAGAACTGGCCTCCCAACCGAGTGCTCAGCCTTCGCCCTTTTCCTCA 641 GTGACTGCAGGTTGTCCAGAGACTGTTCCAAGTGCCAATCAGCTGCAGCAGGCACTGGTGTTGGCATTCTGATTCAATTC 721 TGTGCCTTAGGAGACTGGGAGTTAGAAAACGGACAGGTCCTTGGACTGAGGGAGTTGATTTTTAAAAAGAAATGTTTTAT 801 AAGAAGCCAAGATGTTTGTTTTTCTCCATTCTGAAATGTGTTATAACAATGACCTATTTATGATCTTAAATCTTTTTTTT 881 TTAAAAAGTCTCTGTGTGGTATTTTCATGTTTAAATCCAAATGTAAGAATTGAGCACTGCTCCCAGGCCCGTTCTAATTT 961 ACTTCTTTACTGCACAGAGCTTAGATTTACTACTCACGGTTAGACCTTCGTCACCCAGAACAGGCTCCCTTGGGATAAGC 1041 TTCGGGGAATTTGTTCCAGGATGGTGAGGCTTTGGTGTGTGTTGTTACAGTGAAGACCCTGCAGTTCCTCAGAACTGCAG 1121 TTCAGAAGCAGGGGCGTGGTCTCGGCCCTGCACTTGATGAATATGAAGGAATTCTTTACACGGGGCTCCGGCTCATTTTA 1201 ATTCTCCAAGAAAGTAGATATTAAAATGAGCTGTGTCCATCACAAGGATTTTAGCAAAAAAAAAAAAAAAAAAAAAAAAA 1281 AAGTCAAAGATTAAGGTCAGCAATTTAAGCTGATTGTGTAACCAAACTGTTTTAAAAAACAACAGGCTGGAAATGGTAGG 1361 CCCATATCTTTGGTCCTAGCACTTAGGAGGCAGCAGCAGCAGAATCTCTCTGAGTTCAAAGACAGCCTGGCCTACATAGT 1441 GAGTTCTGGGTCAGTCAGGGCTACATAGAAAGATCCCATCTCAAAAACAGGCAAAAGAAATTCTTTTAGGCTAGTTTTAT 1521 AGCTTAGTCAGAGCACCAGTGTGAGTCCCTGGGTTCCATTCCCACTACCAAAGCCCTGTATTCTAGCTAACATGAAAGCA 1601 ACAGATTTTACAAGTAAAATAGGGATTTCAAGGCTAAAAAACAGTTCTGTCACAAGGTGTTAGCAAGCAGCTTGTAAGTT 1681 AGGAAGCTAACATATGCATCAGCCTGCCTATATCCTGAGTACTGATGAGAAAGTGGGGACTTTGTTGAAACCAGCAATGG 1761 CCTATAAACACGTGAGGAAACACTCCATCTCTGGGCCTTTAAGAAGATCAGCAGTGTTAACCCAGGGTCCTATCAGGACA 1841 ATAAAGTTGCCTAGAATGTGTGAGATCTGTTATTATGGAAAAGTTCCTCAAAATTCAATTTCCTATCATCTGTTTCTGGA 1921 TATGAAATGAAGACAGGGGTGGAATGTTTATACCAGTGCTCATAACAGGATTGTTTGTAATCACCATAAAGAGGAAGCAA 2001 CCTAAGTTCAGAAACAGGTGAGTGGAGAAATGATGGCATGTGCATTAGAAAAATATCCACAGCCAATTCATCCCACTCAA 2081 CATGGATGAACCCACTTACAGGAGATCCCTAGAGGAGCCAATGGTGCCTGAGCCGAGATGAGACACTTGGAGTTAGTATT 2161 TAATGGGTGTGTTGCACAGCAATGTAATACATTTACTGTGATCTAAATACACTCTTTGGTTTCAGATTTAAAAAAAAAAA 2241 AAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Location of target site | 3'UTR |
Article |
- Esau C; Davis S; Murray SF; Yu XX; Pandey et al. - Cell metabolism, 2006
Current understanding of microRNA (miRNA) biology is limited, and antisense oligonucleotide (ASO) inhibition of miRNAs is a powerful technique for their functionalization. To uncover the role of the liver-specific miR-122 in the adult liver, we inhibited it in mice with a 2'-O-methoxyethyl phosphorothioate ASO. miR-122 inhibition in normal mice resulted in reduced plasma cholesterol levels, increased hepatic fatty-acid oxidation, and a decrease in hepatic fatty-acid and cholesterol synthesis rates. Activation of the central metabolic sensor AMPK was also increased. miR-122 inhibition in a diet-induced obesity mouse model resulted in decreased plasma cholesterol levels and a significant improvement in liver steatosis, accompanied by reductions in several lipogenic genes. These results implicate miR-122 as a key regulator of cholesterol and fatty-acid metabolism in the adult liver and suggest that miR-122 may be an attractive therapeutic target for metabolic disease.
LinkOut: [PMID: 16459310]
|
86 mmu-miR-122-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT003075 | Tmem50b | transmembrane protein 50B | ![]() |
1 | 1 | |||||||
MIRT003076 | Lass6 | ceramide synthase 6 | ![]() |
1 | 1 | |||||||
MIRT003077 | Gpx7 | glutathione peroxidase 7 | ![]() |
1 | 1 | |||||||
MIRT003113 | Tgfbr1 | transforming growth factor, beta receptor I | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003114 | Sbk1 | SH3-binding kinase 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003117 | Hist1h1c | histone cluster 1, H1c | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003118 | Ddc | dopa decarboxylase | ![]() |
![]() |
2 | 1 | ||||||
MIRT003120 | Rell1 | RELT-like 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003121 | Bach1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT003122 | Apob | apolipoprotein B | ![]() |
![]() |
2 | 1 | ||||||
MIRT003123 | P4ha1 | procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide | ![]() |
![]() |
2 | 1 | ||||||
MIRT003124 | Ccng1 | cyclin G1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT003125 | Slc7a1 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | ![]() |
![]() |
![]() |
3 | 3 | |||||
MIRT003126 | Gys1 | glycogen synthase 1, muscle | ![]() |
![]() |
2 | 2 | ||||||
MIRT003127 | Slc35a4 | solute carrier family 35, member A4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT003128 | Hfe2 | hemochromatosis type 2 (juvenile) | ![]() |
![]() |
![]() |
3 | 3 | |||||
MIRT003129 | Tmed3 | transmembrane p24 trafficking protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT003132 | Bckdk | branched chain ketoacid dehydrogenase kinase | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT003133 | Aldoa | aldolase A, fructose-bisphosphate | ![]() |
![]() |
![]() |
![]() |
4 | 7 | ||||
MIRT003134 | Ndrg3 | N-myc downstream regulated gene 3 | ![]() |
![]() |
![]() |
![]() |
4 | 2 | ||||
MIRT003135 | Cd320 | CD320 antigen | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT003724 | Smarcd1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003725 | Rcan1 | regulator of calcineurin 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT003726 | Gde1 | glycerophosphodiester phosphodiesterase 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT004536 | Ccrn4l | nocturnin | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT005975 | Klf6 | Kruppel-like factor 6 | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT005976 | B2m | beta-2 microglobulin | ![]() |
1 | 1 | |||||||
MIRT005977 | Afp | alpha fetoprotein | ![]() |
1 | 1 | |||||||
MIRT005978 | Ccl2 | chemokine (C-C motif) ligand 2 | ![]() |
1 | 1 | |||||||
MIRT005979 | Csf3r | colony stimulating factor 3 receptor (granulocyte) | ![]() |
1 | 1 | |||||||
MIRT005980 | Ctgf | connective tissue growth factor | ![]() |
1 | 1 | |||||||
MIRT005981 | Cxcl13 | chemokine (C-X-C motif) ligand 13 | ![]() |
1 | 1 | |||||||
MIRT005982 | Cyp2b13 | cytochrome P450, family 2, subfamily b, polypeptide 13 | ![]() |
1 | 1 | |||||||
MIRT005983 | Dbp | D site albumin promoter binding protein | ![]() |
1 | 1 | |||||||
MIRT005984 | Igf2 | insulin-like growth factor 2 | ![]() |
1 | 1 | |||||||
MIRT005985 | Il1b | interleukin 1 beta | ![]() |
1 | 1 | |||||||
MIRT005986 | Jun | jun proto-oncogene | ![]() |
1 | 1 | |||||||
MIRT005987 | Per1 | period circadian clock 1 | ![]() |
1 | 1 | |||||||
MIRT005988 | Alpl | alkaline phosphatase, liver/bone/kidney | ![]() |
![]() |
2 | 1 | ||||||
MIRT005989 | Cs | citrate synthase | ![]() |
![]() |
2 | 1 | ||||||
MIRT005990 | Prom1 | prominin 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT005991 | Sox4 | SRY (sex determining region Y)-box 4 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT013527 | Uros | uroporphyrinogen III synthase | ![]() |
1 | 1 | |||||||
MIRT013528 | Ppox | protoporphyrinogen oxidase | ![]() |
1 | 1 | |||||||
MIRT013529 | Urod | uroporphyrinogen decarboxylase | ![]() |
1 | 1 | |||||||
MIRT013530 | Cpox | coproporphyrinogen oxidase | ![]() |
1 | 1 | |||||||
MIRT013531 | Fech | ferrochelatase | ![]() |
1 | 1 | |||||||
MIRT013532 | Hamp | hepcidin antimicrobial peptide | ![]() |
1 | 1 | |||||||
MIRT013533 | Tfr2 | transferrin receptor 2 | ![]() |
1 | 1 | |||||||
MIRT013534 | Smad4 | SMAD family member 4 | ![]() |
1 | 1 | |||||||
MIRT013535 | Smad7 | SMAD family member 7 | ![]() |
1 | 1 | |||||||
MIRT013536 | Bmpr1a | bone morphogenetic protein receptor, type 1A | ![]() |
1 | 1 | |||||||
MIRT013537 | Hba-a1 | hemoglobin alpha, adult chain 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT013538 | Hmbs | hydroxymethylbilane synthase | ![]() |
![]() |
2 | 1 | ||||||
MIRT013539 | Mir17 | microRNA 17 | ![]() |
![]() |
2 | 1 | ||||||
MIRT013540 | Alas2 | aminolevulinic acid synthase 2, erythroid | ![]() |
![]() |
2 | 1 | ||||||
MIRT013541 | Mir451 | microRNA 451a | ![]() |
![]() |
2 | 1 | ||||||
MIRT013542 | Tfrc | transferrin receptor | ![]() |
![]() |
2 | 1 | ||||||
MIRT013543 | Socs2 | suppressor of cytokine signaling 2 | ![]() |
1 | 1 | |||||||
MIRT013544 | Slc35g1 | solute carrier family 35, member G1 | ![]() |
1 | 1 | |||||||
MIRT013545 | Camk2b | calcium/calmodulin-dependent protein kinase II, beta | ![]() |
1 | 1 | |||||||
MIRT013546 | Irf6 | interferon regulatory factor 6 | ![]() |
1 | 1 | |||||||
MIRT013547 | Rbl2 | RB transcriptional corepressor like 2 | ![]() |
1 | 1 | |||||||
MIRT013548 | Hfe | hemochromatosis | ![]() |
![]() |
2 | 1 | ||||||
MIRT013549 | Ccnd1 | cyclin D1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT054338 | Pkm | pyruvate kinase, muscle | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT054339 | Tfdp2 | transcription factor Dp 2 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT054340 | E2f1 | E2F transcription factor 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT579817 | Zfp113 | zinc finger protein 113 | ![]() |
1 | 1 | |||||||
MIRT580378 | Tmem206 | transmembrane protein 206 | ![]() |
1 | 2 | |||||||
MIRT581166 | Sec23ip | Sec23 interacting protein | ![]() |
1 | 1 | |||||||
MIRT582514 | March5 | membrane-associated ring finger (C3HC4) 5 | ![]() |
1 | 2 | |||||||
MIRT586941 | H2-T24 | histocompatibility 2, T region locus 24 | ![]() |
1 | 2 | |||||||
MIRT591859 | Iffo2 | intermediate filament family orphan 2 | ![]() |
1 | 1 | |||||||
MIRT592160 | Paxip1 | PAX interacting (with transcription-activation domain) protein 1 | ![]() |
1 | 1 | |||||||
MIRT592189 | Nanog | Nanog homeobox | ![]() |
1 | 2 | |||||||
MIRT592792 | Cdh12 | cadherin 12 | ![]() |
1 | 1 | |||||||
MIRT597026 | Thap1 | THAP domain containing, apoptosis associated protein 1 | ![]() |
1 | 1 | |||||||
MIRT597210 | Snhg11 | small nucleolar RNA host gene 11 | ![]() |
1 | 1 | |||||||
MIRT601300 | Zfp949 | zinc finger protein 949 | ![]() |
1 | 1 | |||||||
MIRT602608 | Chrna1 | cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) | ![]() |
1 | 1 | |||||||
MIRT602960 | Xpo7 | exportin 7 | ![]() |
1 | 1 | |||||||
MIRT603391 | Sgol2 | shugoshin 2A | ![]() |
1 | 1 | |||||||
MIRT604008 | Ggps1 | geranylgeranyl diphosphate synthase 1 | ![]() |
1 | 1 | |||||||
MIRT605553 | Ppp1r16b | protein phosphatase 1, regulatory (inhibitor) subunit 16B | ![]() |
1 | 1 | |||||||
MIRT606204 | Sfxn4 | sideroflexin 4 | ![]() |
1 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|